{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:07Z","timestamp":1792801927933,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Folate receptor delta (FR\u03b4) has been used as a biomarker for regulatory T cells (Tregs), because its expression is limited to Tregs and ovum. Although FR\u03b4 is unable to bind folate, we have used molecular docking software to identify a folate congener that binds FR\u03b4 with high affinity and have exploited this FR\u03b4-specific ligand to target attached drugs (imaging agents, immune activators, and immune suppressors) specifically to Tregs in murine tumor xenografts. Analysis of treated tumors demonstrates that targeting of a Toll-like receptor 7 agonist inhibits Treg expression of FOXP3, PD-1, CTLA4, and HELIOS, resulting in 40-80% reduction in tumor growth and repolarization of other tumor-infiltrating immune cells to more inflammatory phenotypes. Targeting of the immunosuppressive drug dexamethasone, in contrast, promotes enhanced tumor growth and shifts the tumor-infiltrating immune cells to more anti-inflammatory phenotypes. Since Tregs comprise &amp;lt;1% of cells in the tumor masses examined, and since the targeted drugs are not internalized by cancer cells, these data demonstrate that Tregs exert a disproportionately large effect on tumor growth. Because the targeted drug did not bind to Tregs or other immune cells in healthy tissues, the data demonstrate that the immunosuppressive properties of Tregs in tumors can be manipulated without causing systemic toxicities associated with global reprogramming of the immune system.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1274199","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:43:42Z","timestamp":1697802222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth"],"prefix":"10.3389","volume":"14","author":[{"given":"Rami","family":"Alfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Napoleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imrul","family":"Shahriar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Finnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Walchle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0391-5","article-title":"Constitutive immune mechanisms: mediators of host defence and immune regulation","volume":"21","author":"Paludan","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572186","article-title":"Revisiting the pathoetiology of multiple sclerosis: has the tail been wagging the mouse","volume":"11","author":"Sen","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10731","DOI":"10.1038\/s41598-020-67710-2","article-title":"Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach","volume":"10","author":"Garc\u00eda","year":"2020","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0121TR","article-title":"Immune mechanisms in pulmonary fibrosis","volume":"55","author":"Kolahian","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2016.00056","article-title":"Immune dysfunction in cirrhosis","volume":"5","author":"Noor","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","article-title":"Immune dysfunction and risk of infection in chronic kidney disease","volume":"26","author":"Syed-Ahmed","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197165","article-title":"Innate immunity effector cells as inflammatory drivers of cardiac fibrosis","volume":"21","author":"Baci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.12170","article-title":"Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation","volume":"259","author":"Smigiel","year":"2014","journal-title":"Immunol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.4110\/in.2020.20.e4","article-title":"Regulatory T cells in tumor microenvironment and approach for anticancer immunotherapy","volume":"20","author":"Kim","year":"2020","journal-title":"Immune Netw"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.05.016","article-title":"Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells","volume":"25","author":"Pacholczyk","year":"2006","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12967-019-1967-3","article-title":"Blockade of TGF-\u03b2 signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25\u2013Foxp3+ T cells","volume":"17","author":"Polanczyk","year":"2019","journal-title":"J Trans Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502139","article-title":"Cutting edge: regulatory T cells facilitate cutaneous wound healing","volume":"196","author":"Nosbaum","year":"2016","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.07.022","article-title":"FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets","volume":"490","author":"Saleh","year":"2020","journal-title":"Cancer Lett"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0296-3","article-title":"Modulation of regulatory T cell function and stability by co-inhibitory receptors","volume":"20","author":"Lucca","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.05.011","article-title":"Depletion of regulatory T cells by targeting folate receptor 4 enhances the potency of a GM-CSF-secreting tumor cell immunotherapy","volume":"148","author":"Liang","year":"2013","journal-title":"Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0895","article-title":"Low-dose cyclophosphamide induces antitumor T-cell responses, which associate with survival in metastatic colorectal cancer","volume":"23","author":"Scurr","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.050","article-title":"Targeting EZH2 reprograms intratumoral regulatory T cells to enhance cancer immunity","volume":"23","author":"Wang","year":"2018","journal-title":"Cell Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86182","article-title":"PD-1(+) and Foxp3(+) T cell reduction correlates with survival of HCC patients after sorafenib therapy","volume":"1","author":"Kalathil","year":"2016","journal-title":"JCI Insight"},{"key":"B23","doi-asserted-by":"crossref","first-page":"e1372079","DOI":"10.1080\/2162402X.2017.1372079","article-title":"Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer","volume":"7","author":"Liu","year":"2017","journal-title":"Oncoimmunology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191009","article-title":"Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells","volume":"217","author":"Tanaka","year":"2020","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7150\/jca.69375","article-title":"BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC","volume":"13","author":"Wang","year":"2022","journal-title":"J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature13203","article-title":"Juno is the egg Izumo receptor and is essential for mammalian fertilization","volume":"508","author":"Bianchi","year":"2014","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343469","article-title":"Identification of novel markers for mouse CD4(+) T follicular helper cells","volume":"43","author":"Iyer","year":"2013","journal-title":"Eur J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/ma14030534","article-title":"Raltitrexed-modified gold and silver nanoparticles for targeted cancer therapy: cytotoxicity behavior in vitro on A549 and HCT-116 human cancer cells","volume":"14","author":"Morey","year":"2021","journal-title":"Materials"},{"key":"B30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clcc.2018.09.010","article-title":"Efficacy and cardiotoxic safety profile of raltitrexed in fluoropyrimidines-pretreated or high-risk cardiac patients with GI Malignancies: large single-center experience","volume":"18","author":"Khan","year":"2019","journal-title":"Clin Colorectal Cancer."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115572","article-title":"Folate receptor beta as a direct and indirect target for antibody-based cancer immunotherapy","volume":"22","author":"Roy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1414","article-title":"Folate receptor beta designates immunosuppressive tumor-associated myeloid cells that can be reprogrammed with folate-targeted drugs","volume":"81","author":"Cresswell","year":"2021","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-018-0589-2","article-title":"The folate receptor \u03b2 as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis","volume":"9","author":"Chandrupatla","year":"2019","journal-title":"Drug Deliv Transl Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150789","article-title":"A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages","volume":"113","author":"Xia","year":"2009","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012034","article-title":"Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosis","volume":"12","author":"Zhang","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14485","article-title":"Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN-amplified neuroblastoma cells","volume":"111","author":"Yamashita","year":"2020","journal-title":"Cancer Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02453","article-title":"T regulatory cells and priming the suppressive tumor microenvironment","volume":"10","author":"Paluskievicz","year":"2019","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8458","article-title":"CD86(+)\/CD206(+) tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma","volume":"8","author":"Sun","year":"2020","journal-title":"PeerJ"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.04.090","article-title":"Dysregulation of humoral immunity in Foxp3 conditional-knockout mice","volume":"513","author":"Tai","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062465","article-title":"Lack of Foxp3 function and expression in the thymic epithelium","volume":"204","author":"Liston","year":"2007","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-230X-12-97","article-title":"Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation","volume":"12","author":"Boehm","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e2114282119","DOI":"10.1073\/pnas.2114282119","article-title":"CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory","volume":"119","author":"Kidani","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.10.6940","article-title":"CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ Regulatory and th2 effector lymphocytes","volume":"177","author":"Soler","year":"2006","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1038\/s41598-019-45653-7","article-title":"CCR8 leads to eosinophil migration and regulates neutrophil migration in murine allergic enteritis","volume":"9","author":"Blanco-P\u00e9rez","year":"2019","journal-title":"Sci Rep"},{"key":"B46","article-title":"JUNO, the receptor of sperm IZUMO1, is expressed by the human oocyte and is essential for human fertilisation","volume":"34","author":"Jean","year":"2018","journal-title":"Hum Reprod"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20170065","article-title":"Location and expression of Juno in mice oocytes during maturation","volume":"21","author":"Suzuki","year":"2017","journal-title":"JBRA Assist Reprod"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0144248","DOI":"10.1371\/journal.pone.0144248","article-title":"Melamine impairs female fertility via suppressing protein level of juno in mouse eggs","volume":"10","author":"Dai","year":"2015","journal-title":"PloS One"},{"key":"B49","first-page":"59","article-title":"Mutation analysis of the JUNO gene in female infertility of unknown etiology","volume":"2","author":"Takaiso","year":"2016","journal-title":"Fujita Med J"},{"key":"B50","doi-asserted-by":"crossref","first-page":"e2221255120","DOI":"10.1073\/pnas.2221255120","article-title":"Treg cells require Izumo1R to regulate \u03b3\u03b4T cell-driven inflammation in the skin","volume":"120","author":"Zarin","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S231052","article-title":"Cancer immunotherapies targeting tumor-associated regulatory T cells","volume":"12","author":"Ge","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1820388116","article-title":"Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity","volume":"116","author":"Onda","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br J Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601118","article-title":"Are regulatory T cells defective in type 1 diabetes and can we fix them","volume":"197","author":"Visperas","year":"2016","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2035117","DOI":"10.1080\/21645515.2022.2035117","article-title":"Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders \u2013 Advances and challenges","volume":"18","author":"Goswami","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020287","article-title":"CAR-T regulatory (CAR-treg) cells: engineering and applications","volume":"10","author":"Arjomandnejad","year":"2022","journal-title":"Biomedicines"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197015","article-title":"Treg enhancing therapies to treat autoimmune diseases","volume":"21","author":"Eggenhuizen","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1274199\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:43:47Z","timestamp":1697802227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1274199\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2023.1274199"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1274199","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"article-number":"1274199"}}